CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Clinical trial NCT06783309 · RECRUITING

Trial details

NCT number: NCT06783309
Sponsor: COUR Pharmaceutical Development Company, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus T1D T1DM T1DM - Type 1 Diabetes Mellitus Type 1 Diabetes in Adolescence Type 1 Diabetes in Children Type 1 Diabetes (Juvenile Onset)Type 1 Diabetes Type 1 Diabetes Patients Type 1 Diabetes Mellitis

Start date: 2025-05-12
Primary completion: 2026-12-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.